vs
MACROGENICS INC(MGNX)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是MACROGENICS INC的1.9倍($78.6M vs $41.2M),MACROGENICS INC同比增速更快(113.0% vs 0.4%),MACROGENICS INC自由现金流更多($42.8M vs $23.2M),过去两年MACROGENICS INC的营收复合增速更高(112.8% vs -1.3%)
MacroGenics Inc是一家临床阶段生物制药公司,专注于研发针对癌症和自身免疫性疾病的新型免疫疗法,核心产品管线以单克隆抗体类治疗药物为核心,重点项目覆盖实体瘤与血液恶性肿瘤,通过与全球药企合作推进产品落地。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
MGNX vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.9倍
$41.2M
营收增速更快
MGNX
高出112.6%
0.4%
自由现金流更多
MGNX
多$19.5M
$23.2M
两年增速更快
MGNX
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $41.2M | $78.6M |
| 净利润 | — | $-140.1M |
| 毛利率 | — | 74.2% |
| 营业利润率 | -29.3% | -182.2% |
| 净利率 | — | -178.3% |
| 营收同比 | 113.0% | 0.4% |
| 净利润同比 | — | -3304.1% |
| 每股收益(稀释后) | $-0.23 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
MGNX
RPAY
| Q4 25 | $41.2M | $78.6M | ||
| Q3 25 | $72.8M | $77.7M | ||
| Q2 25 | $22.2M | $75.6M | ||
| Q1 25 | $13.2M | $77.3M | ||
| Q4 24 | $19.4M | $78.3M | ||
| Q3 24 | $110.7M | $79.1M | ||
| Q2 24 | $10.8M | $74.9M | ||
| Q1 24 | $9.1M | $80.7M |
净利润
MGNX
RPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $16.8M | $-6.4M | ||
| Q2 25 | $-36.3M | $-102.3M | ||
| Q1 25 | $-41.0M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $56.3M | $3.2M | ||
| Q2 24 | $-55.7M | $-4.1M | ||
| Q1 24 | $-52.2M | $-5.2M |
毛利率
MGNX
RPAY
| Q4 25 | — | 74.2% | ||
| Q3 25 | — | 74.4% | ||
| Q2 25 | — | 75.7% | ||
| Q1 25 | — | 75.9% | ||
| Q4 24 | 98.8% | 76.3% | ||
| Q3 24 | 99.8% | 77.8% | ||
| Q2 24 | 98.4% | 78.2% | ||
| Q1 24 | 97.0% | 76.2% |
营业利润率
MGNX
RPAY
| Q4 25 | -29.3% | -182.2% | ||
| Q3 25 | 25.6% | -3.9% | ||
| Q2 25 | -165.3% | -138.7% | ||
| Q1 25 | -323.1% | -4.7% | ||
| Q4 24 | -273.0% | -1.5% | ||
| Q3 24 | 48.9% | -0.9% | ||
| Q2 24 | -538.9% | -4.6% | ||
| Q1 24 | -590.4% | -3.1% |
净利率
MGNX
RPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | 23.1% | -8.3% | ||
| Q2 25 | -163.0% | -135.2% | ||
| Q1 25 | -311.1% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | 50.9% | 4.1% | ||
| Q2 24 | -515.6% | -5.4% | ||
| Q1 24 | -573.3% | -6.5% |
每股收益(稀释后)
MGNX
RPAY
| Q4 25 | $-0.23 | $-1.68 | ||
| Q3 25 | $0.27 | $-0.08 | ||
| Q2 25 | $-0.57 | $-1.15 | ||
| Q1 25 | $-0.65 | $-0.09 | ||
| Q4 24 | $-0.24 | $-0.04 | ||
| Q3 24 | $0.90 | $0.03 | ||
| Q2 24 | $-0.89 | $-0.04 | ||
| Q1 24 | $-0.84 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $57.2M | $115.7M |
| 总债务越低越好 | — | $280.1M |
| 股东权益账面价值 | $55.6M | $484.4M |
| 总资产 | $256.8M | $1.2B |
| 负债/权益比越低杠杆越低 | — | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
MGNX
RPAY
| Q4 25 | $57.2M | $115.7M | ||
| Q3 25 | $80.1M | $95.7M | ||
| Q2 25 | $130.7M | $162.6M | ||
| Q1 25 | $145.6M | $165.5M | ||
| Q4 24 | $182.8M | $189.5M | ||
| Q3 24 | $179.6M | $168.7M | ||
| Q2 24 | $83.9M | $147.1M | ||
| Q1 24 | $80.4M | $128.3M |
总债务
MGNX
RPAY
| Q4 25 | — | $280.1M | ||
| Q3 25 | — | $279.5M | ||
| Q2 25 | — | $279.0M | ||
| Q1 25 | — | $497.6M | ||
| Q4 24 | — | $496.8M | ||
| Q3 24 | — | $496.2M | ||
| Q2 24 | — | $435.6M | ||
| Q1 24 | — | $434.9M |
股东权益
MGNX
RPAY
| Q4 25 | $55.6M | $484.4M | ||
| Q3 25 | $67.0M | $616.9M | ||
| Q2 25 | $46.6M | $633.7M | ||
| Q1 25 | $79.1M | $755.7M | ||
| Q4 24 | $116.1M | $761.3M | ||
| Q3 24 | $120.1M | $754.7M | ||
| Q2 24 | $57.8M | $815.4M | ||
| Q1 24 | $106.2M | $813.8M |
总资产
MGNX
RPAY
| Q4 25 | $256.8M | $1.2B | ||
| Q3 25 | $270.8M | $1.3B | ||
| Q2 25 | $245.4M | $1.4B | ||
| Q1 25 | $224.6M | $1.5B | ||
| Q4 24 | $261.7M | $1.6B | ||
| Q3 24 | $264.5M | $1.6B | ||
| Q2 24 | $201.1M | $1.5B | ||
| Q1 24 | $248.3M | $1.5B |
负债/权益比
MGNX
RPAY
| Q4 25 | — | 0.58× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.44× | ||
| Q1 25 | — | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $43.0M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $42.8M | $23.2M |
| 自由现金流率自由现金流/营收 | 103.8% | 29.6% |
| 资本支出强度资本支出/营收 | 0.6% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-83.0M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
MGNX
RPAY
| Q4 25 | $43.0M | $23.3M | ||
| Q3 25 | $-30.2M | $32.2M | ||
| Q2 25 | $-47.0M | $33.1M | ||
| Q1 25 | $-46.9M | $2.5M | ||
| Q4 24 | $-38.4M | $34.3M | ||
| Q3 24 | $60.2M | $60.1M | ||
| Q2 24 | $-44.5M | $31.0M | ||
| Q1 24 | $-45.6M | $24.8M |
自由现金流
MGNX
RPAY
| Q4 25 | $42.8M | $23.2M | ||
| Q3 25 | $-30.6M | $32.1M | ||
| Q2 25 | $-47.7M | $33.0M | ||
| Q1 25 | $-47.4M | $2.4M | ||
| Q4 24 | $-39.0M | $34.0M | ||
| Q3 24 | $59.6M | $59.8M | ||
| Q2 24 | $-45.5M | $30.5M | ||
| Q1 24 | $-47.1M | $24.7M |
自由现金流率
MGNX
RPAY
| Q4 25 | 103.8% | 29.6% | ||
| Q3 25 | -42.0% | 41.3% | ||
| Q2 25 | -214.5% | 43.6% | ||
| Q1 25 | -359.5% | 3.0% | ||
| Q4 24 | -201.7% | 43.5% | ||
| Q3 24 | 53.8% | 75.6% | ||
| Q2 24 | -421.6% | 40.7% | ||
| Q1 24 | -517.4% | 30.6% |
资本支出强度
MGNX
RPAY
| Q4 25 | 0.6% | 0.1% | ||
| Q3 25 | 0.6% | 0.2% | ||
| Q2 25 | 3.2% | 0.1% | ||
| Q1 25 | 4.0% | 0.2% | ||
| Q4 24 | 3.2% | 0.3% | ||
| Q3 24 | 0.5% | 0.3% | ||
| Q2 24 | 9.6% | 0.6% | ||
| Q1 24 | 16.0% | 0.1% |
现金转化率
MGNX
RPAY
| Q4 25 | — | — | ||
| Q3 25 | -1.79× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.07× | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MGNX
| Revenue From Collaborative Agreements | $20.3M | 49% |
| Contract Manufacturing | $11.3M | 27% |
| Other | $9.7M | 23% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |